Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (281-290 of 350) with videos related to

Pageof 35
Sort By:
Acta Neuropathologica|September 14, 2020
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entityLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.
Acta Neuropathologica|April 25, 2026
Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomasRamin Rahmanzade, Leonille Schweizer, Simone Schmid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.
Acta Neuropathologica|February 10, 2016
Methylation-based classification of benign and malignant peripheral nerve sheath tumorsManuel Röhrich, Christian Koelsche, Daniel Schrimpf, et al.
Acta Neuropathologica|December 30, 2021
Oligosarcomas, IDH-mutant are distinct and aggressiveAbigail K Suwala, Marius Felix, Dennis Friedel, et al.
Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Acta Neuropathologica Communications|April 4, 2024
EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnosticsJürgen Hench, Claus Hultschig, Jon Brugger, et al.
Journal of the National Cancer Institute|December 16, 2015
TERT Promoter Mutations and Risk of Recurrence in MeningiomaFelix Sahm, Daniel Schrimpf, Adriana Olar, et al.
Neuro-Oncology|December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
Acta Neuropathologica|October 6, 2022
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusionsZhichao Wu, Sharika Rajan, Hye-Jung Chung, et al.
Pageof 35

Showing results (281-290 of 350) with videos related to

Sort By:
Pageof 35
Acta Neuropathologica|September 14, 2020
Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entityLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.
Acta Neuropathologica|April 25, 2026
Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomasRamin Rahmanzade, Leonille Schweizer, Simone Schmid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.
Acta Neuropathologica|February 10, 2016
Methylation-based classification of benign and malignant peripheral nerve sheath tumorsManuel Röhrich, Christian Koelsche, Daniel Schrimpf, et al.
Acta Neuropathologica|December 30, 2021
Oligosarcomas, IDH-mutant are distinct and aggressiveAbigail K Suwala, Marius Felix, Dennis Friedel, et al.
Nature Communications|July 22, 2018
Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastomaMatija Snuderl, Kasthuri Kannan, Elke Pfaff, et al.
Acta Neuropathologica Communications|April 4, 2024
EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnosticsJürgen Hench, Claus Hultschig, Jon Brugger, et al.
Journal of the National Cancer Institute|December 16, 2015
TERT Promoter Mutations and Risk of Recurrence in MeningiomaFelix Sahm, Daniel Schrimpf, Adriana Olar, et al.
Neuro-Oncology|December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
Acta Neuropathologica|October 6, 2022
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusionsZhichao Wu, Sharika Rajan, Hye-Jung Chung, et al.
Pageof 35